Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Global HIV Therapeutics Market Analysis
Format : 
Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Dec, 2011| No. of Pages : 70
Please make your selection :
Electronic Access - Single User License
US$ 1200.00
CD-ROM Mail Delivery
US$ 1400.00
Hard Copy Mail Delivery
US$ 1400.00
Electronic Access - Multi-User License
US$ 1800.00
1. Analyst View
2. Research Methodology
3. Global HIV/AIDS Therapeutics Market Overview
3.1 Disease Overview
3.2 Market Overview
4. Major Marketed Products
4.1 Atripla
4.2 Truvada
4.3 Kaletra
4.4 Reyataz
4.5 Fuzeon
4.6 Sustiva
5. Country-level Analysis
5.1 US
5.2 Europe
5.3 Japan
5.4 India
6. Pipeline Analysis
7. Recent Developments
7.1 Drug Approvals
7.2 Licensing Agreements
8. Investment Pattern
9. Competitive Assessment
9.1 Gilead Sciences, Inc
9.2 Bristol-Myers Squibb
9.3 GlaxoSmithKline
9.4 Abbott Laboratories
9.5 Pfizer
9.6 Merck
Not able to find data you are looking for? Ask our Research Analyst.
media citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2018, RNCOS, 2002-2018
About Us
Terms & Policy
Contact